<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74">
 <label>74.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Senzer</surname>
    <given-names>NN</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Kaufman</surname>
    <given-names>HL</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Amatruda</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <etal/>
  <article-title>Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma</article-title>. 
  <source>J. Clin. Oncol.</source>
  <volume>27</volume>(
  <issue>34</issue>), 
  <fpage>5763</fpage>â€“
  <lpage>5771</lpage> (
  <year>2009</year>).
  <pub-id pub-id-type="pmid">19884534</pub-id>
 </mixed-citation>
</ref>
